BridgeMD

Sign in

Hpv Vaccine clinical trials

Explore recruiting hpv vaccine clinical trials.

Recruiting hpv vaccine studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hpv Vaccine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

VAC-WARTS Efficacy of the nonavalent HPV vaccine in the treatment of difficult-to-treat palmo-plantar warts

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

CONDYVAC. Efficacy study of the quadrivalent Human Papilloma Virus (HPV) vaccine to prevent recurrence of External Genital Warts (EGW) in patients who were cured in the first place

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective longitudinal study on immunogenicity, induction of cellular immune responses and safety of vaccination against HPV with the 9valent vaccine in HIV-positive women The Papillon study

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Immunogenicity of 9-valent HPV vaccine in immunocompromised children and adolescents

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related high-grade squamous intraepithelial lesions.(BioHPV)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hpv Vaccine trials by city

Hpv Vaccine in Toronto Hpv Vaccine in Vancouver Hpv Vaccine in Montreal Hpv Vaccine in Calgary Hpv Vaccine in Edmonton Hpv Vaccine in Ottawa Hpv Vaccine in Winnipeg Hpv Vaccine in Quebec City Hpv Vaccine in Hamilton Hpv Vaccine in Kitchener Hpv Vaccine in London Hpv Vaccine in Halifax Hpv Vaccine in New York Hpv Vaccine in Los Angeles Hpv Vaccine in Chicago Hpv Vaccine in Houston